Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medi-Weightloss vs Navio MD

Medi-Weightloss
Graded #118

Lower grade

vs+0.20000000000000284
Navio MD
Graded #112

Higher grade

The verdict

Navio MD takes it — 69.8/100 to 69.6/100, but only just.

Navio MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo). Medi-Weightloss is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNavio MD +3
54
57
Dose & formulationNavio MD +12
65
77
Clinical oversightEven
87
87
Labs & monitoringMedi-Weightloss +36
90
54
FulfillmentNavio MD +20
65
85
Contract termsEven
55
55
Medi-Weightloss · left barNavio MD · right bar

The numbers

MetricMedi-WeightlossNavio MD
WeighScore69.6/10069.8/100
GradeCC
Scorecard rank#118#112
Semaglutide$199/mo (promotional rate, brand-name)$345/mo (starting dose, brand-name)
TirzepatideNot disclosed$189/mo (starting dose, compounded)
CoverageCoverage not published48 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Medi-Weightloss

Graded #118 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated
Navio MD

Graded #112 · C

Strengths

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

Where it loses points

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard